Skip to main content
SpringerLink
Log in

Immunsuppression

Immunosuppression

  • Conference paper
Uveitis

  • 6 Accesses

Zusammenfassung

Nach Erwähnung der Überlegungen, die dem Einsatz der immunsuppressiven Zytostatika bei Uveitis zugrunde liegen, werden die heute dafür verwendeten Medikamente und ihre Wirkungsweise vorgestellt Speziell wird dabei auf die an der Zürcher Universitätsaugenklinik gebrauchte Kombination von Zyklophosphamid und Prokarbazin hingewiesen. Es werden die absoluten und relativen Indikationen dieser Behandlung angegeben und die mit der obigen Therapie erzielten Resultate erwähnt. Schließlich werden für die 15–20% Mißerfolge solcher Behandlungen Hinweise auf andere therapeutische Möglichkeiten (Immunostimulation, Chirurgie) gegeben.

Summary

After some considerations about the necessity for an immunosuppressive therapy in severe uveitis, the currently available drugs are listed, with special reference to cyclophosphamide and procarbazine, the drug combination actually used at the University Eye Clinic in Zurich. The absolute and relative indications for these therapies are given as well as the obtained results. For the 15–20% failures, alternative treatment such as immunostimulation or surgery is proposed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aoki K, Sugiura S (1976) Immunosuppressive treatment of Behçet’s disease. Mod Probl Ophthalmol 16:309–313.

    CAS  PubMed  Google Scholar 

  • Bietti GB, Cerulli L, Pivetti-Pezzi P (1976) Behçet’s disease and immunsuppressive treatment. Our personal experience. Mod Probl Ophthalmol 16:314–323.

    CAS  PubMed  Google Scholar 

  • Bonnet M (1978) Sept ans et demi d’expérience du traitement du syndrome de Behçet par les immunodépresseurs. Bull Soc Ophtalmol Fr 78:315–316.

    CAS  PubMed  Google Scholar 

  • Campinchi R (1970) Les immunosuppresseurs chimiques. Dans: Campinchi R, Faure JP, Bloch-Michel E, Haut J L’uvéite, phénomènes immunologiques et allergiques. Masson, Paris, p 798–820.

    Google Scholar 

  • Caren LD, Rosenberg LT (1966) Steroids and serum complements in mice: influence of hydrocortisone, diethylstilboestrol and testosterone. Science 152:782–783.

    Article  CAS  PubMed  Google Scholar 

  • Firat MD (1978) Results of immunosuppressive treatment in Behçet’s disease. Ann Ophthalmol 10:1421–1423.

    CAS  PubMed  Google Scholar 

  • Fraunfelder FT (1980) Interim report: national registry of possible drug induced ocular side-effects. Ophthalmology 87:87–90.

    Article  CAS  PubMed  Google Scholar 

  • Friedlaender MH (1979) Ocular allergy and immunology. J Allergy Clin Immunol 63:51–60.

    Article  CAS  PubMed  Google Scholar 

  • Friedmann R, Buckler ChE (1963) Methotrexate inhibition of tuberculin hypersensitivity in inbred guinea pigs. J Immunol 91:846–850.

    Google Scholar 

  • Godfrey WA, Epstein WV, O’Connor GR, Kimura SJ, Hogan MJ, Nozik RA (1974) The use of chlorambucil in intractible idiopathic uveitis. Am J Ophthalmol 78:415–428.

    CAS  PubMed  Google Scholar 

  • Hall JM, Ohno S (1977) The effect of cyclophosphamide on an ocular immune response. Clin Exp Immunol 30:309–316.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hersh EM, Carbone PP, Wong VG, Freireich EJ (1965) Inhibition of the primary immune response in man by anti-metabolites. Cancer Res 25:1177–1181.

    Google Scholar 

  • Hersh EM, Wong VG, Freireich EJ (1966) Inhibition of the local inflammatory response in man by antimetabolites. Blood 27:38–48.

    CAS  PubMed  Google Scholar 

  • Hijikata K, Masuda K (1978) Visual prognosis in Behçet’s disease: effects of cyclophosphamide and colchicine. Jpn J Ophthalmol 22:506–519.

    Google Scholar 

  • James DG (1977) Immunotherapy. Trans Ophthalmol Soc UK 97:468–473.

    CAS  PubMed  Google Scholar 

  • Kadoya M, Okinami S (1979) Treatment of Behçet’s disease with immunosuppressive agents and colchicine. Acta Soc Ophthalmol Jpn 83:200–206.

    CAS  Google Scholar 

  • Kastler M, Bloch-Michel E (1970) Dans: Campinchi R, Faure JP, Bloch-Michel E, Haut J L’uvéite. Masson, Paris, p 832–838.

    Google Scholar 

  • Makley TA, Azar A (1978) Sympathetic ophthalmia. A longterm follow-up. Arch Ophthalmol 96:257–262.

    Article  PubMed  Google Scholar 

  • Martenet AC, Verrey F, Witmer R (1965) Influence d’un nouveau cytostatique, dérivé de la méthylhydrazine sur l’uvéite expérimentale du lapin. Ophthalmologica (Basel) 150:97–106.

    Article  CAS  Google Scholar 

  • Martenet AC, Witmer R (1970) Immunosuppressive therapy in eye diseases. In: Miescher PA (ed) Immunsuppressive therapy. Schwabe, Stuttgart, pp 101–108.

    Google Scholar 

  • Martenet AC (1974) Maladie de Behçet, évolution sous immunodépresseurs. Proc XXII. Conc Ophthalmol. Masson, Paris, p 488–492.

    Google Scholar 

  • Martenet AC (1980) Les échecs des cytostatiques en ophtalmologie. Klin Monatsbl Augenheilkd 176:648–651.

    Article  CAS  PubMed  Google Scholar 

  • Martenet AC (1975) Problèmes et échecs de la corticothérapie dans les uvéites. Bull Mém Soc Fr Ophtalmol 87:35–37.

    Google Scholar 

  • Mikuni I, Fujiwara T (1978) Experimental cataract in vitro induced by antimetabolites. Acta Soc Ophthalmol Jpn 82:282–287.

    CAS  Google Scholar 

  • Nozik A, Godfrey A, Epstein V, O’Connor G, Kimura J, Hogan MJ (1976) Immunosuppressive treatment of uveitis. Mod Probl Ophthalmol 16:305–308.

    CAS  PubMed  Google Scholar 

  • O’Connor GR (1976) Discussion on immunosuppressive therapy. Mod Probl Ophthalmol 16:326.

    Google Scholar 

  • Ring J, Dechant W, Seifert J, Lund OE, Greite JH, Stefani FH, Brendel W (1978) Immunosuppression with ALG in the treatment of ophthalmic disorders. Ophthalmic Res 10:82–97.

    Article  Google Scholar 

  • Rocha H (1977) Der Transferfaktor in der Ophthalmologie. Klin Monatsbl Augenheilkd 171:63–70.

    CAS  PubMed  Google Scholar 

  • Roda-Perez E (1961) Sobre un caso de uveitis de etiologia ignota tratado con mostaza nitrogenada. Rev Clin Esp 40:265–267.

    Google Scholar 

  • Roda-Perez E (1953) El tratamiento de las uveitis de etiologia ignota con mostaza nitrogenada. Arch Soc Oftalmol Hisp-Am 12:131–151.

    Google Scholar 

  • Rosenau W, Moon HD (1962) The inhibitory effect of hydrocortisone on lysis of homologous cells by lymphocytes in vitro. J Immunol 89:422–426.

    CAS  PubMed  Google Scholar 

  • Rosselet E, Saudan Y, Zenklusen G (1968) Les effets de l’azathioprine (imuran) dans la maladie de Behçet, Premiers résultats thérapeutiques. Ophthalmologica Basel 156:218–226.

    Article  CAS  Google Scholar 

  • Victoria-Troncoso V (1976) Discussion on immunosuppressive therapy. Mod Probl Ophthalmol 16:327.

    Google Scholar 

  • Wirotsko E, Halbert S (1962) Suppression of allergic uveitis by 6-mercaptopurin. J Exp Med 116:653–664.

    Article  Google Scholar 

  • Witmer R (1964) A propos du traitement de l’uvéite. Bull Mém Soc Fr Ophtalmol 77:596–603.

    Google Scholar 

  • Wong VG, Hersh EM (1965) Methotrexate in the therapy of cyclitis. Trans Am Acad Ophthalmol Otolaryngol 69:279–293.

    Google Scholar 

  • Wong VG, Hersh EM, McMaster PRB (1966) Treatment of a presumed case of sympathetic ophthalmia with methotrexate. Arch Ophthalmol 76:66–76

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Univ.-Augenklinik Zürich, Schweiz

    A.-C. Martenet

Authors
  1. A.-C. Martenet
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitäts-Augenklinik, Bergheimer Str. 20, D-6900, Heidelberg, Deutschland

    Wolfgang Jaeger

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Martenet, AC. (1981). Immunsuppression. In: Jaeger, W. (eds) Uveitis. Deutsche Ophthalmologische Gesellschaft Bericht über die 78. Zusammenkunft in Kiel 1980, vol 78. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-88589-1_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-88589-1_42

  • Publisher Name: J.F. Bergmann-Verlag, Munich

  • Print ISBN: 978-3-8070-0325-2

  • Online ISBN: 978-3-642-88589-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation